Buller David B, English Dallas R, Buller Mary Klein, Simmons Jody, Chamberlain James A, Wakefield Melanie, Dobbinson Suzanne
David B. Buller and Mary Klein Buller are with Klein Buendel, Inc., Golden, CO. Dallas R. English is with the Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia. Jody Simmons, Melanie Wakefield, and Suzanne Dobbinson are with the Centre for Behavioural Research in Cancer, Cancer Council Victoria, Melbourne. James A. Chamberlain is with the Cancer Epidemiology Centre, Cancer Council Victoria.
Am J Public Health. 2017 Dec;107(12):1869-1875. doi: 10.2105/AJPH.2017.304071. Epub 2017 Oct 19.
To test whether shade sails will increase the use of passive recreation areas (PRAs).
We conducted a stratified randomized pretest-posttest controlled design study in Melbourne, Australia, and Denver, Colorado, in 2010 to 2014. We randomized a sample of 144 public parks with 2 PRAs in full sun in a 1:3 ratio to treatment or control. Shade sails were built at 1 PRA per treatment park. The outcome was any use of the study PRA (n = 576 pretest and n = 576 posttest observations; 100% follow-up).
Compared with control PRAs (adjusted probability of use: pretest = 0.14, posttest = 0.17), use of treatment PRAs (pretest = 0.10, posttest = 0.32) was higher at posttest (odds ratio [OR] = 3.91; 95% confidence interval [CI] = 1.71, 8.94). Shade increased use of PRAs in Denver (control: pretest = 0.18, posttest = 0.19; treatment: pretest = 0.16, posttest = 0.47) more than Melbourne (control: pretest = 0.11, posttest = 0.14; shaded: pretest = 0.06, posttest = 0.19; OR = 2.98; 95% CI = 1.09, 8.14).
Public investment in shade is warranted for skin cancer prevention and may be especially useful in the United States.
Clinicaltrials.gov identifier NCT02971709.
测试遮阳帆是否会增加被动休闲区(PRA)的使用。
2010年至2014年,我们在澳大利亚墨尔本和科罗拉多州丹佛进行了一项分层随机前测-后测对照设计研究。我们将144个有两个完全暴露在阳光下的PRA的城市公园样本按1:3的比例随机分为治疗组或对照组。每个治疗组公园的一个PRA安装了遮阳帆。结果是研究PRA的任何使用情况(前测n = 576,后测n = 576观察值;100%随访)。
与对照PRA相比(调整后的使用概率:前测 = 0.14,后测 = 0.17),治疗组PRA的使用情况(前测 = 0.10,后测 = 0.32)在后测时更高(优势比[OR] = 3.91;95%置信区间[CI] = 1.71, 。遮阳在丹佛增加PRA的使用(对照组:前测 = 0.18,后测 = 0.19;治疗组:前测 = 0.16,后测 = 0.47)比墨尔本更多(对照组:前测 = 0.11,后测 = 0.14;遮阳组:前测 = 0.06,后测 = 0.19;OR = 2.98;95% CI = 1.09, 8.14)。
为预防皮肤癌,对遮阳设施进行公共投资是有必要的,在美国可能尤其有用。
Clinicaltrials.gov标识符NCT02971709。 8.94)